Structure−Activity Relationship Studies of Novel Heteroretinoids: Induction of Apoptosis in the HL-60 Cell Line by a Novel Isoxazole-Containing Heteroretinoid
- 4 November 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (24) , 4961-4969
Abstract
In a search for retinoic acid receptor (RAR and RXR)-selective ligands, a series of isoxazole retinoids was synthesized and evaluated in vitro in transcriptional activation and competition binding assays for RARs and RXRs. In addition, these compounds were evaluated for their differentiating, cytotoxic, and apoptotic activities. In general, these derivatives showed scarcely any binding affinity and were not active in the transcriptional assay. However, among these isoxazole derivatives, the cis-isomer 14b was identified as a potent inducer of apoptosis, and its activity was found to be 6.5 and 4 times superior than that of 13-cis- and 9-cis-retinoic acids, respectively. On the other hand, compound 13b, which has the trans stereochemistry at the double bond, was found not to be active in the apoptotic assay, but it was endowed with appreciable differentiating activity. Therefore, it seems that the different stereochemistry of the double bond may be associated with a different biological activity: potent apoptotic activity for the cis-isomer but differentiating activity for the trans structure. This biological behavior was found, at least in part, for the 9-cis- and 13-cis-retinoic acids with respect to the all-trans-retinoic acid. Thus, structure 14b could offer an interesting model for the design of new compounds endowed with apoptotic activity.Keywords
This publication has 17 references indexed in Scilit:
- The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosisCell Death & Differentiation, 1998
- A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARα-mediated signals in myeloid leukemic cellsLeukemia Research, 1998
- Retinoic Acid Conjugates as Potential Antitumor Agents: Synthesis and Biological Activity of Conjugates with Ara-A, Ara-C, 3(2H)-Furanone, and Aniline Mustard MoietiesJournal of Medicinal Chemistry, 1997
- Possible Involvement of Bcl-2 Pathway in Retinoid X Receptor Alpha-Induced Apoptosis of HL-60 CellsBiochemical and Biophysical Research Communications, 1997
- Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia CellsJournal of Medicinal Chemistry, 1995
- Apoptosis and cancer: the failure of controls on cell death and cell survivalCritical Reviews in Oncology/Hematology, 1995
- Cancer Therapy Meets p53New England Journal of Medicine, 1994
- Head and Neck CancerNew England Journal of Medicine, 1993
- Synthesis of some isoxazole analogues of retinoids: biological effects toward tumor cell linesSynthèse de quelques dérivés isoxazoliques analogues des rétinoides. Effects biologiques vis-à-vis des cellules tumoralesEuropean Journal of Medicinal Chemistry, 1990
- A [3+2] nitrile oxide cycloaddition approach to retinoidsTetrahedron Letters, 1988